Share-based Payment Arrangement, Expense of REGENXBIO Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
REGENXBIO Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • REGENXBIO Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $8,998,000, a 9% decline year-over-year.
  • REGENXBIO Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $35,730,000, a 4.1% decline year-over-year.
  • REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2024 was $38,463,000, a 4.5% decline from 2023.
  • REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40,267,000, a 1.3% decline from 2022.
  • REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2022 was $40,788,000, a 5.1% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

REGENXBIO Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $35,730,000 $8,998,000 -$886,000 -9% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $36,616,000 $8,653,000 -$782,000 -8.3% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $37,398,000 $8,537,000 -$1,065,000 -11% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $38,463,000 $9,542,000 +$1,204,000 +14% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 $37,259,000 $9,884,000 -$335,000 -3.3% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $37,594,000 $9,435,000 -$1,069,000 -10% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $38,663,000 $9,602,000 -$1,604,000 -14% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $40,267,000 $8,338,000 -$1,070,000 -11% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $41,337,000 $10,219,000 -$26,000 -0.25% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $41,363,000 $10,504,000 +$169,000 +1.6% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 $41,194,000 $11,206,000 +$406,000 +3.8% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $40,788,000 $9,408,000 +$246,000 +2.7% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2025 2024 FY
Q3 2022 $40,542,000 $10,245,000 +$511,000 +5.2% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $40,031,000 $10,335,000 +$343,000 +3.4% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 $39,688,000 $10,800,000 +$880,000 +8.9% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 $38,808,000 $9,162,000 +$1,581,000 +21% 01 Oct 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
Q3 2021 $37,227,000 $9,734,000 +$1,699,000 +21% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $35,528,000 $9,992,000 +$1,676,000 +20% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $33,852,000 $9,920,000 +$1,903,000 +24% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $31,949,000 $7,581,000 +$706,000 +10% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $31,243,000 $8,035,000 +$873,000 +12% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $30,370,000 $8,316,000 +$1,217,000 +17% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $29,153,000 $8,017,000 +$2,299,000 +40% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $26,854,000 $6,875,000 +$1,990,000 +41% 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $24,864,000 $7,162,000 +$2,679,000 +60% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020 2020 Q3
Q2 2019 $22,185,000 $7,099,000 +$3,117,000 +78% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $19,068,000 $5,718,000 +$2,427,000 +74% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $16,641,000 $4,885,000 +$2,088,000 +75% 01 Oct 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
Q3 2018 $14,553,000 $4,483,000 +$1,749,000 +64% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019 2019 Q3
Q2 2018 $12,804,000 $3,982,000 +$1,499,000 +60% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $11,305,000 $3,291,000 +$700,000 +27% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q4 2017 $10,605,000 $2,797,000 +$797,000 +40% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
Q3 2017 $9,808,000 $2,734,000 +$905,000 +49% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $8,903,000 $2,483,000 +$827,000 +50% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $8,076,000 $2,591,000 +$1,045,000 +68% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q4 2016 $7,031,000 $2,000,000 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
Q3 2016 $1,829,000 +$480,000 +36% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $1,656,000 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $1,546,000 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q3 2015 $1,349,000 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3

REGENXBIO Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $38,463,000 -$1,804,000 -4.5% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $40,267,000 -$521,000 -1.3% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $40,788,000 +$1,980,000 +5.1% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2025 2024 FY
2021 $38,808,000 +$6,859,000 +21% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $31,949,000 +$5,095,000 +19% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $26,854,000 +$10,213,000 +61% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $16,641,000 +$6,036,000 +57% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $10,605,000 +$3,574,000 +51% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $7,031,000 +$4,110,000 +141% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $2,921,000 +$2,602,000 +816% 01 Jan 2015 31 Dec 2015 10-K 06 Mar 2018 2017 FY
2014 $319,000 01 Jan 2014 31 Dec 2014 10-K 07 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.